Medico Remedies Ltd.
Snapshot View

317.00 +3.05 ▲1.0%

31 January 2023, 04:01:00 PM
Volume: 3,708

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
Market Cap 526.12 Cr.
Enterprise Value(EV) 538.21 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.95 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 107.59 Trailing Twelve Months Ending 2022-03
Industry PE 32.54 Trailing Twelve Months Ending 2022-03
Book Value / Share 23.97 Trailing Twelve Months Ending 2022-03
Price to Book Value 13.22 Calculated using Price: 317.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.66 Cr. 16,596,800 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.97%
1 Week
+4.19%
1 Month
-3.03%
3 Month
+62.69%
6 Month
+248.35%
1 Year
+291.36%
2 Year
+1525.64%
5 Year
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.23 7.14 7.97 10.47 5.67 5.72 5.61 8.31 14.02
Return on Capital Employed (%) 11.37 10.01 10.86 9.39 9.05 7.79 7.66 10.13 15.00
Return on Assets (%) 2.54 2.36 2.78 3.47 2.26 2.31 2.15 3.43 6.44

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 9 14 15 16 27 28 30 32 37 40
Non Curr. Liab. 1 1 4 11 3 3 5 5 1 3
Curr. Liab. 22 22 26 21 30 45 40 38 38 54
Minority Int.
Equity & Liab. 31 36 46 48 59 76 75 76 76 96
Non Curr. Assets 8 10 9 10 14 17 19 17 18 22
Curr. Assets 23 26 37 38 46 59 57 58 59 74
Misc. Exp. not W/O
Total Assets 31 36 46 48 59 76 75 76 76 96

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 34 45 51 67 54 61 98 89 122 121
Other Income 0 0 0 0 0 1 2 2 1 2
Total Income 34 45 51 67 55 62 100 91 123 123
Total Expenditure -32 -43 -48 -63 -50 -58 -95 -86 -117 -114
PBIDT 2 2 3 4 4 4 5 5 6 9
Interest 0 -1 -1 -1 -1 -2 -1 -1 -1 -1
Depreciation 0 -1 -1 -1 -1 -1 -2 -2 -2 -2
Taxation 0 0 0 -1 0 -1 -1 -1 -1 -2
Exceptional Items 0
PAT 0 1 1 1 2 1 2 2 3 5
Adjusted EPS 1 1 1 1 1 1 1 1 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 0 -4 -3 5 5 1 -11 2
Cash Fr. Inv. -2 -4 -2 0 -3 -5 -4 -3 -17 -3
Cash Fr. Finan. 0 2 3 2 6 -1 -1 3 18 7
Net Change 0 1 0 -1 0 -1 0 0 -10 6
Cash & Cash Eqvt 0 1 2 1 0 0 0 1 -10 6

Shareholding Pattern View Details >>

9 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34
Public 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 12.94 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 13 Jan 2023
Board Meeting Intimation for Announcement Of Board Meeting As Per Regulation 29 Of SEBI (LODR) Regulations 2015
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Pursuant to Regulation 29(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 2nd February 2023 inter alia to consider and approve:1. Sub-division/ Stock Split of equity shares of the Company.2. Any other matter with the permission of the Chair.
Tue, 27 Dec 2022
Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended & Companys Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading in its securities the Trading Window for dealing in the equity shares of the Company will be closed for all Insiders Designated Persons and their immediate relatives from 1st January 2023 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 31st December 2022.
Tue, 15 Nov 2022
Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Investor Presentation for Q2 FY 2022-23 of the Company.

Technical Scans View Details >>

Tue, 31 Jan 2023
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,034.50 -1.6%
Divi's Laboratories Ltd. 88,067.87 3,315.30 -1.5%
Cipla Ltd. 82,086.54 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. 72,004.82 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. 61,188.28 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. 51,492.78 1,521.45 -1.7%
Abbott India Ltd. 44,288.65 20,785.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.96 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.43 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 31.11 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.72 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.88 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.96 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 50.23 20,785.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.68 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.26 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 3.62 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.26 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.22 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.08 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 16.32 20,785.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,785.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,785.15 -0.9%

FAQ's On Medico Remedies Ltd.

What is Medico Remedies share price?

Can I buy Medico Remedies shares now?

What is the Market Cap of Medico Remedies?

What are the key metrics to analyse Medico Remedies?

What is the 52 Week High and Low of Medico Remedies?

What is the trend of Medico Remedies share price?